CCR6 and rheumatoid arthritis: Furthermore, the findings in the CCR6+ memTh-RASF functional coculture model provide a rationale for a clinical trial combining low-dose 1,25(OH)2D3 and DEX with TNFα blockade to improve disease management in RA.